209 related articles for article (PubMed ID: 21477893)
21. Opioid-induced respiratory depression resulting from transdermal fentanyl-clarithromycin drug interaction in a patient with advanced COPD.
Horton R; Barber C
J Pain Symptom Manage; 2009 Jun; 37(6):e2-5. PubMed ID: 19500718
[No Abstract] [Full Text] [Related]
22. Long-term dosing, safety, and tolerability of fentanyl buccal tablet in the management of noncancer-related breakthrough pain in opioid-tolerant patients.
Nalamachu SR; Narayana A; Janka L
Curr Med Res Opin; 2011 Apr; 27(4):751-60. PubMed ID: 21288055
[TBL] [Abstract][Full Text] [Related]
23. Impact of transdermal fentanyl on quality of life in rheumatoid arthritis.
Berliner MN; Giesecke T; Bornhövd KD
Clin J Pain; 2007; 23(6):530-4. PubMed ID: 17575494
[TBL] [Abstract][Full Text] [Related]
24. Opioids in non-cancer pain: a life-time sentence?
Dellemijn PL
Eur J Pain; 2001; 5(3):333-9. PubMed ID: 11558990
[TBL] [Abstract][Full Text] [Related]
25. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
26. Fentanyl patches: preventable overdose.
Prescrire Int; 2010 Feb; 19(105):22-5. PubMed ID: 20455338
[TBL] [Abstract][Full Text] [Related]
27. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain.
Otis J; Rothman M
Curr Med Res Opin; 2006 Aug; 22(8):1493-501. PubMed ID: 16870074
[TBL] [Abstract][Full Text] [Related]
28. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
29. Fentanyl intoxication caused by abuse of transdermal fentanyl.
Moon JM; Chun BJ
J Emerg Med; 2011 Jan; 40(1):37-40. PubMed ID: 18455903
[TBL] [Abstract][Full Text] [Related]
30. [The use of transdermal fentanyl in chronic non-malignant pain].
Akkaya T; Sayin M; Gümüş H
Agri; 2005 Jan; 17(1):39-44. PubMed ID: 15791499
[TBL] [Abstract][Full Text] [Related]
31. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
[TBL] [Abstract][Full Text] [Related]
32. Transdermal fentanyl in cancer patients with moderate-to-severe pain: a prospective examination.
Iconomou G; Viha A; Vagenakis AG; Kalofonos HP
Anticancer Res; 2000; 20(6C):4821-4. PubMed ID: 11205226
[TBL] [Abstract][Full Text] [Related]
33. Sticking to the safe side with fentanyl patches.
D'Arcy Y
Nursing; 2009 Mar; 39(3):62-3. PubMed ID: 19247136
[No Abstract] [Full Text] [Related]
34. [Treatment of chronic pain--use of transdermal fentanyl (Durogesic TTS)].
Babić-Naglić D; Jajić Z; Gnjidić Z; Stambuk B
Reumatizam; 2002; 49(2):33-7. PubMed ID: 12476759
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of transdermal fentanyl in patients with cancer pain: phase IV, Turkish oncology group trial.
Kömürcü S; Turhal S; Altundağ K; Atahan L; Turna HS; Manavoğlu O; Yavuz AA; Ozkök S; Aliustaoğlu M; Altinbaş M; Pak Y; Cooper R; Yaylaci M; Demirkan B; Sarihan S; Ozdemir F
Eur J Cancer Care (Engl); 2007 Jan; 16(1):67-73. PubMed ID: 17227355
[TBL] [Abstract][Full Text] [Related]
36. Failure of pain control using transdermal fentanyl during rifampicin treatment.
Morii H; Chiba M; Konishi H; Endo Y; Yamaji A
J Pain Symptom Manage; 2007 Jan; 33(1):5-6. PubMed ID: 17196900
[No Abstract] [Full Text] [Related]
37. Long-term safety and tolerability of fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic pain: an 18-month study.
Fine PG; Messina J; Xie F; Rathmell J
J Pain Symptom Manage; 2010 Nov; 40(5):747-60. PubMed ID: 20594801
[TBL] [Abstract][Full Text] [Related]
38. The absence of 'cross-tolerance' when switching from oral morphine to transdermal fentanyl.
Johnson S; Faull C
Palliat Med; 1997 Nov; 11(6):494-5. PubMed ID: 9519176
[No Abstract] [Full Text] [Related]
39. Transdermal fentanyl: caution in the use of high doses.
Botterman J; De Meester C; Eeckhaut K
Palliat Med; 2004 Oct; 18(7):663. PubMed ID: 15540677
[No Abstract] [Full Text] [Related]
40. [Research from the Palliative Care Department in Poznań on treatment of neoplasm pain with Durogesic (transdermal fentanyl)].
Leppert W; Luczak J; Gorzelińska L; Kozikowska J
Przegl Lek; 2000; 57(1):59-64. PubMed ID: 10907375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
